Steven Batki, MD

Title(s)Professor, Psychiatry
SchoolSchool of Medicine
Address4150 Clement Street, #101
San Francisco CA 94121
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine

    Collapse Overview 
    Collapse Overview
    Steven L. Batki, M.D. is Professor of Psychiatry, in Residence, at the University of California, San Francisco (UCSF) School of Medicine and Chief of the Substance Abuse Programs and Director of the Addiction Psychiatry Research Program at the San Francisco VA Medical Center (SFVAMC), where he also directs the UCSF Addiction Psychiatry Fellowship Program. Dr. Batki is engaged in addiction research, training, and clinical services.

    Dr. Batki’s research and clinical interests include pharmacologic treatment for addiction to alcohol, opioids, and stimulants. His work focuses on psychiatric and medical disorders that co-occur with addiction, such as such as PTSD, traumatic brain injury (TBI), schizophrenia, and HIV/HCV. He has published extensively on clinical research in addiction and co-occurring disorders. He chaired the SAMSHA CSAT Treatment Improvement Protocol No. 37, Substance Abuse Treatment for Persons with HIV/AIDS, and Treatment Improvement Protocol No. 43, Medication-Assisted Treatment for Opioid Dependence.

    Dr. Batki's current research is supported by the Department of Defense and NIDA. His DoD projects are examining the effectiveness of pharmacotherapy for alcohol use disorders in veterans with posttraumatic stress disorder (PTSD) as well as in veterans with mild traumatic brain injury (TBI). Dr. Batki is also conducting NIDA-funded research on the pharmacotherapy of methamphetamine dependence. Recently completed NIDA and NIAAA work has included the study of hepatitis C treatment in injection drug users and the pharmacological treatment of alcohol dependence in schizophrenia.

    Collapse Research 
    Collapse Research Activities and Funding
    Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder
    NIH R44AA027188Sep 20, 2018 - May 31, 2023
    Role: Co-Principal Investigator
    Mirtazapine for the treatment of methamphetamine dependence among MSM with high-r
    NIH R01DA034527Feb 1, 2013 - Jan 31, 2019
    Role: Co-Principal Investigator
    Naltrexone for the treatment of Actively-Using Met-Dependent MSM with High-Risk B
    NIH R01DA031678Jun 1, 2011 - Jul 31, 2017
    Role: Co-Principal Investigator
    Improving Hepatitis C Treatment in Injection Drug Users
    NIH R01DA016764Sep 26, 2003 - Jun 30, 2010
    Role: Principal Investigator
    Naltrexone Treatment of Alcohol Abuse in Schizophrenia
    NIH R01AA013655Apr 1, 2003 - Mar 31, 2009
    Role: Principal Investigator
    NIH R01DA011397Feb 20, 1998 - Dec 31, 2002
    Role: Principal Investigator
    Treatment for Complex Patients: Continuing and Extended Care
    NIH P50DA009253Sep 29, 1994 - May 31, 2016
    Role: Co-Investigator
    NIH R01DA008526Aug 1, 1994 - Jun 30, 1998
    Role: Principal Investigator
    NIH P50DA001696Feb 1, 1978 - Aug 31, 2000
    Role: Co-Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis. Hepatol Commun. 2024 Feb 01; 8(2). Luk JW, Satre DD, Cheung R, Wong RJ, Monto A, Chen JY, Batki SL, Ostacher MJ, Snyder HR, Shui AM, Liao M, Haight CG, Khalili M. PMID: 38315141; PMCID: PMC10843394.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    2. N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial. Contemp Clin Trials. 2023 08; 131:107250. Herbst ED, Pennington DL, Borsari B, Manuel J, Yalch M, Alcid E, Martinez Rivas M, Delacruz J, Rossi N, Garcia B, Wong N, Batki SL. PMID: 37271412; PMCID: PMC10847050.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCTClinical Trials
    3. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial. Contemp Clin Trials. 2023 03; 126:107096. Vowles KE, Witkiewitz K, Clarke E, Schmidt Z, Borsari B, Edwards KE, Korecki JR, Moniz-Lewis DI, Bondzie JA, Mullins C, Thoreson CI, Delacruz J, Wilkins CH, Nelson S, Delventura J, Henderson R, Katz A, Hua W, Watson E, Baxley C, Canlas BR, Pendleton T, Herbst E, Batki S. PMID: 36693589; PMCID: PMC10308452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addict Behav. 2023 04; 139:107589. Baxley C, Borsari B, Reavis JV, Manuel JK, Herbst E, Becker W, Pennington D, Batki SL, Seal K. PMID: 36565531.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial. Am J Psychiatry. 2022 12 01; 179(12):915-926. Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, McLaughlin M, Jain J, Arenander J, Vittinghoff E, Batki S. PMID: 36285404; PMCID: PMC10072332.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Impact of Alcohol Use, Traumatic Stress, and Cigarette Smoking on Cognitive Functioning in Veterans With Co-occurring Alcohol Use Disorder and Posttraumatic Stress Disorder. Mil Med. 2022 Sep 30. Hua JPY, Cano M, Batki SL, Pennington DL. PMID: 36179109; PMCID: PMC10362996.
      View in: PubMed   Mentions: 1     Fields:    
    7. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161. Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME, PRIME Care Research Group, Aslam M, Batki SL, Bjork JM, Blow FC, Brenner LA, Chen P, Desai S, Dieperink EW, Fears SC, Fuller MA, Goodman CS, Graham DP, Haas GL, Hamner MB, Helstrom AW, Hurley RA, Icardi MS, Jurjus GJ, Kilbourne AM, Kreyenbuhl J, Lache DJ, Lieske SP, Lynch JA, Meyer LJ, Montalvo C, Muralidhar S, Ostacher MJ, Paschall GY, Pfeiffer PN, Prieto S, Przygodzki RM, Ranganathan M, Rodriguez-Suarez MM, Roggenkamp H, Schichman SA, Schneeweis JS, Simonetti JA, Steinhauer SR, Suppes T, Umbert MA, Vassy JL, Voora D, Wiechers IR, Wood AE. PMID: 35819423; PMCID: PMC9277497.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    8. The Impact of Exercise and Virtual Reality Executive Function Training on Cognition Among Heavy Drinking Veterans With Traumatic Brain Injury: A Pilot Feasibility Study. Front Behav Neurosci. 2022; 16:802711. Pennington DL, Reavis JV, Cano MT, Walker E, Batki SL. PMID: 35391785; PMCID: PMC8981916.
      View in: PubMed   Mentions: 4  
    9. Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial. Front Psychiatry. 2021; 12:804997. Stauffer CS, Samson S, Hickok A, Hoffman WF, Batki SL. PMID: 35111090; PMCID: PMC8801418.
      View in: PubMed   Mentions: 1  
    10. Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial. PLoS One. 2021; 16(7):e0254724. Santos GM, Ikeda J, Coffin P, Walker JE, Matheson T, McLaughlin M, Jain J, Vittinghoff E, Batki SL. PMID: 34265007; PMCID: PMC8282062.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Working memory and alcohol demand relationships differ according to PTSD symptom severity among veterans with AUD. Exp Clin Psychopharmacol. 2021 Apr; 29(2):166-177. Abram SV, Batki SL, Pennington DL. PMID: 34043400.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial. Sleep. 2020 10 13; 43(10). Neylan TC, Richards A, Metzler TJ, Ruoff LM, Varbel J, O'Donovan A, Sivasubramanian M, Motraghi T, Hlavin J, Batki SL, Inslicht SS, Samuelson K, Morairty SR, Kilduff TS. PMID: 32303763; PMCID: PMC7551303.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    13. A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms. Drug Alcohol Depend. 2020 09 01; 214:108149. Pennington DL, Bielenberg J, Lasher B, Herbst E, Abrams G, Novakovic-Agopian T, Batki SL. PMID: 32712569; PMCID: PMC8370467.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial. JAMA Psychiatry. 2020 03 01; 77(3):246-255. Coffin PO, Santos GM, Hern J, Vittinghoff E, Walker JE, Matheson T, Santos D, Colfax G, Batki SL. PMID: 31825466; PMCID: PMC6990973.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    15. Care of the Transgender Patient. Ann Intern Med. 2019 11 19; 171(10):775. Herbst ED, Harris E, Pennington DL, Batki SL. PMID: 31739319.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial. Alcohol Clin Exp Res. 2019 12; 43(12):2627-2636. Stauffer CS, Meinzer NK, Morrison T, Wen JH, Radanovich L, Leung D, Niles A, O'Donovan A, Batki SL, Woolley JD. PMID: 31610033; PMCID: PMC7450809.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines. Subst Abus. 2018; 39(4):441-448. Zaman T, Rife TL, Batki SL, Pennington DL. PMID: 29595408.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Mobile Technology for Treatment Augmentation in Veteran Smokers With Posttraumatic Stress Disorder. Am J Prev Med. 2018 Jan; 54(1):124-128. Herbst E, Pennington D, Kuhn E, McCaslin SE, Delucchi K, Batki SL, Dickter B, Carmody T. PMID: 29074319.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    19. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial. Addiction. 2018 02; 113(2):268-278. Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL. PMID: 28734107; PMCID: PMC5760469.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    20. Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco. J Subst Abuse Treat. 2017 04; 75:43-48. Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM. PMID: 28237053; PMCID: PMC5367385.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    21. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder. J Clin Psychiatry. 2016 09; 77(9):1182-1188. Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC. PMID: 27035058.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Relations Between Cognitive Functioning and Alcohol Use, Craving, and Post-Traumatic Stress: An Examination Among Trauma-Exposed Military Veterans With Alcohol Use Disorder. Mil Med. 2016 07; 181(7):663-71. Heinz AJ, Pennington DL, Cohen N, Schmeling B, Lasher BA, Schrodek E, Batki SL. PMID: 27391620; PMCID: PMC4940120.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study. Psychopharmacology (Berl). 2016 07; 233(13):2571-80. Woolley JD, Arcuni PA, Stauffer CS, Fulford D, Carson DS, Batki S, Vinogradov S. PMID: 27137199; PMCID: PMC7452038.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    24. Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):21-30. Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL. PMID: 26674372; PMCID: PMC4837026.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    25. What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia? J Clin Psychiatry. 2015 Oct; 76(10):e1336-7. Batki SL. PMID: 26528663.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015 Oct; 69:150-7. Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. PMID: 26343607.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    27. Behavioral treatment of insomnia in early recovery. J Addict Med. 2014 Nov-Dec; 8(6):395-8. Kaplan KA, McQuaid J, Batki SL, Rosenlicht N. PMID: 25369939.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder. Psychiatry Res. 2014 Dec 30; 224(3):281-7. Pennington DL, Abé C, Batki SL, Meyerhoff DJ. PMID: 25444536; PMCID: PMC4254450.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    29. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug; 38(8):2169-77. Batki SL, Pennington DL, Lasher B, Neylan TC, Metzler T, Waldrop A, Delucchi K, Herbst E. PMID: 25092377; PMCID: PMC4146719.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    30. Cognitive-behavioral therapy in depressed primary care patients with co-occurring problematic alcohol use: effect of telephone-administered vs. face-to-face treatment-a secondary analysis. J Psychoactive Drugs. 2014 Apr-Jun; 46(2):85-92. Kalapatapu RK, Ho J, Cai X, Vinogradov S, Batki SL, Mohr DC. PMID: 25052784; PMCID: PMC4110640.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Toward personalized medicine in the pharmacotherapy of alcohol use disorder: targeting patient genes and patient goals. Am J Psychiatry. 2014 Apr; 171(4):391-4. Batki SL, Pennington DL. PMID: 24687193.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder. Mil Med. 2013 Sep; 178(9):974-80. Kalapatapu RK, Delucchi KL, Lasher BA, Vinogradov S, Batki SL. PMID: 24005546; PMCID: PMC3815580.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial. J Clin Psychopharmacol. 2013 Apr; 33(2):243-7. Meszaros ZS, Abdul-Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL. PMID: 23422399.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    34. Team-based learning exercise efficiently teaches brief intervention skills to medicine residents. Subst Abus. 2013; 34(4):344-9. Wamsley MA, Julian KA, O'Sullivan P, McCance-Katz EF, Batki SL, Satre DD, Satterfield J. PMID: 24159904.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders. J Addict Dis. 2013; 32(2):206-16. Kalapatapu RK, Lewis DF, Vinogradov S, Batki SL, Winhusen T. PMID: 23815427; PMCID: PMC3703837.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    36. Using standardized patients to evaluate screening, brief intervention, and referral to treatment (SBIRT) knowledge and skill acquisition for internal medicine residents. Subst Abus. 2012; 33(3):303-7. Satterfield JM, O'Sullivan P, Satre DD, Tsoh JY, Batki SL, Julian K, McCance-Katz EF, Wamsley M. PMID: 22738010.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    37. Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder. Schizophr Res. 2011 Nov; 132(2-3):190-3. Meszaros ZS, Dimmock JA, Ploutz-Snyder R, Chauhan SV, Abdul-Malak Y, Middleton FA, Batki SL. PMID: 21852074; PMCID: PMC3195925.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Predictors of smoking severity in patients with schizophrenia and alcohol use disorders. Am J Addict. 2011 Sep-Oct; 20(5):462-7. Meszaros ZS, Dimmock JA, Ploutz-Snyder RJ, Abdul-Malak Y, Leontieva L, Canfield K, Batki SL. PMID: 21838846; PMCID: PMC3156655.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment. Am J Addict. 2011 Jul-Aug; 20(4):312-8. Batki SL, Canfield KM, Ploutz-Snyder R. PMID: 21679262; PMCID: PMC4651620.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    40. Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study. J Addict Dis. 2010 Jul; 29(3):359-69. Batki SL, Canfield KM, Smyth E, Ploutz-Snyder R, Levine RA. PMID: 20635285; PMCID: PMC4651622.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. The description and evaluation of the implementation of an integrated healthcare model. Fam Syst Health. 2010 Jun; 28(2):146-60. Funderburk JS, Sugarman DE, Maisto SA, Ouimette P, Schohn M, Lantinga L, Wray L, Batki S, Nelson B, Coolhart D, Strutynski K. PMID: 20695672.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol. 2010 Jun; 69(6):578-92. Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL. PMID: 20565449; PMCID: PMC2883750.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansAnimals
    43. Pregabalin treatment of anxiety in patients with substance use disorders. Ann Pharmacother. 2010 May; 44(5):937-8. Raza S, Siddiqui UA, Megna JL, Schwartz TL, Batki SL. PMID: 20388860.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection. Subst Use Misuse. 2010 Mar; 45(4):496-514. Canfield KM, Smyth E, Batki SL. PMID: 20141461.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. Drug Alcohol Depend. 2009 May 01; 101(3):176-82. Batki SL, Canfield KM, Smyth E, Ploutz-Snyder R. PMID: 19233573.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    46. Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophrenia. Am J Drug Alcohol Abuse. 2009; 35(5):273-8. Leontieva L, Dimmock J, Cavallerano M, DeRycke S, Meszaros Z, Carey K, Ploutz-Snyder R, Batki SL. PMID: 19591067; PMCID: PMC4651625.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophr Res. 2009 Feb; 107(2-3):139-46. Batki SL, Meszaros ZS, Strutynski K, Dimmock JA, Leontieva L, Ploutz-Snyder R, Canfield K, Drayer RA. PMID: 19022627; PMCID: PMC2649875.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    48. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia. Schizophr Res. 2008 Oct; 105(1-3):201-7. Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R. PMID: 18701256; PMCID: PMC2582942.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):199-206. Gruber VA, Delucchi KL, Kielstein A, Batki SL. PMID: 18243585; PMCID: PMC2821580.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    50. Voucher-based incentives for naltrexone treatment attendance in schizophrenia and alcohol use disorders. Psychiatr Serv. 2008 Mar; 59(3):310-4. Leontieva L, Dimmock JA, Gately PW, Gallinger L, Ploutz-Snyder R, Batki SL. PMID: 18308913.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008; 22(11):903-16. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. PMID: 18840032.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    52. Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders. Am J Addict. 2007 Jul-Aug; 16(4):253-9. Batki SL, Dimmock JA, Wade M, Gately PW, Cornell M, Maisto SA, Carey KB, Ploutz-Snyder R. PMID: 17661192.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    53. Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders. Clin Psychol (New York). 2007 Mar; 14(1):39-57. Carey KB, Leontieva L, Dimmock J, Maisto SA, Batki SL. PMID: 19081784; PMCID: PMC2600522.
      View in: PubMed   Mentions: 2     Fields:    
    54. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. PMID: 17056206; PMCID: PMC1976289.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    55. Lamotrigine-associated rash and blood dyscrasias in a methadone-treatment patient with hepatitis C. Psychosomatics. 2006 May-Jun; 47(3):257-8. Alleyne S, Alao A, Batki SL. PMID: 16684944.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Rural jail telepsychiatry: a pilot feasibility study. Telemed J E Health. 2005 Oct; 11(5):574-7. Manfredi L, Shupe J, Batki SL. PMID: 16250821.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    57. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. PMID: 16184072; PMCID: PMC2599914.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    58. Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues. Am J Drug Alcohol Abuse. 2004 Nov; 30(4):765-82. Harris DS, Batki SL, Berger SP. PMID: 15624548.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    59. Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am J Addict. 2004 Oct-Dec; 13(5):461-70. Batki SL, Harris DS. PMID: 15764424.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    60. Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies. J Affect Disord. 2002 Sep; 71(1-3):71-83. Escamilla MA, Batki S, Reus VI, Spesny M, Molina J, Service S, Vinogradov S, Neylan T, Mathews C, Meza L, Gallegos A, Montero AP, Cruz ML, Neuhaus J, Roche E, Smith L, Leon P, Freimer NB. PMID: 12167503.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet. 2002 Sep; 71(3):565-74. Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, Molina J, Fournier E, Gallegos A, Mathews C, Neylan T, Batki SL, Roche E, Ramirez M, Silva S, De Mille MC, Dong P, Leon PE, Reus VI, Sandkuijl LA, Freimer NB. PMID: 12119601; PMCID: PMC379193.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    62. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002 May 01; 66(3):283-93. Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K. PMID: 12062463.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    63. Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend. 2002 Mar 01; 66(1):45-50. Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, Perlman DC. PMID: 11850135.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    64. Urine toxicology samples in cocaine treatment trials: how many need to be tested? J Addict Dis. 2002; 21(2):17-26. Delucchi KL, Batki SL, Moon J, Jacob P, Jones RT. PMID: 11916369.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    65. Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11485-90. McInnes LA, Service SK, Reus VI, Barnes G, Charlat O, Jawahar S, Lewitzky S, Yang Q, Duong Q, Spesny M, Araya C, Araya X, Gallegos A, Meza L, Molina J, Ramirez R, Mendez R, Silva S, Fournier E, Batki SL, Mathews CA, Neylan T, Glatt CE, Escamilla MA, Luo D, Gajiwala P, Song T, Crook S, Nguyen JB, Roche E, Meyer JM, Leon P, Sandkuijl LA, Freimer NB, Chen H. PMID: 11572994; PMCID: PMC58756.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    66. Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. Am J Med Genet. 2001 Mar 08; 105(2):207-13. Escamilla MA, McInnes LA, Service SK, Spesny M, Reus VI, Molina J, Gallegos A, Fournier E, Batki S, Neylan T, Matthews C, Vinogradov S, Roche E, Tyler DJ, Shimayoshi N, Mendez R, Ramirez R, Ramirez M, Araya C, Araya X, Leon PE, Sandkuijl LA, Freimer NB. PMID: 11304838.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    67. Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv. 2000 Apr; 51(4):474-8. Schiller MJ, Shumway M, Batki SL. PMID: 10737822.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    68. Patterns of substance use among patients in an urban psychiatric emergency service. Psychiatr Serv. 2000 Jan; 51(1):113-5. Schiller MJ, Shumway M, Batki SL. PMID: 10647144.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict. 2000; 9(1):28-37. Harris D, Batki SL. PMID: 10914291.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    70. Substance abuse and HIV infection. New Dir Ment Health Serv. 2000; (87):57-67. Ferrando SJ, Batki SL. PMID: 11031802.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis. Ann N Y Acad Sci. 2000; 909:260-3. Batki SL, Moon J, Delucchi K, Bradley M, Hersh D, Smolar S, Mengis M, Lefkowitz E, Sexe D, Morello L, Everhart T, Jones RT, Jacob P. PMID: 10911936.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    72. Sulfonium salts as derivatizing agents. 3. Quantitation of the cocaine metabolite benzoylecgonine in urine using gas chromatography with ion-pair extraction/on-column alkylation. J Anal Toxicol. 1999 Nov-Dec; 23(7):581-5. Panganiban K, Jacob P, Everhart ET, Tisdale EC, Batki SL, Mendelson JE, Jones RT. PMID: 10595843.
      View in: PubMed   Mentions: 1     Fields:    Translation:CellsPHPublic Health
    73. Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet. 1999 Jun; 64(6):1670-8. Escamilla MA, McInnes LA, Spesny M, Reus VI, Service SK, Shimayoshi N, Tyler DJ, Silva S, Molina J, Gallegos A, Meza L, Cruz ML, Batki S, Vinogradov S, Neylan T, Nguyen JB, Fournier E, Araya C, Barondes SH, Leon P, Sandkuijl LA, Freimer NB. PMID: 10330354; PMCID: PMC1377910.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    74. Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care. 1998 Jun; 10(3):297-312. Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M. PMID: 9828973.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    75. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction. 1998 Apr; 93(4):475-86. Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA, Santos E, Casadonte P, Fye C, Stine S, Wang RI, Segal D. PMID: 9684386.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCTClinical Trials
    76. Buprenorphine and naloxone interactions in methadone maintenance patients. Biol Psychiatry. 1997 Jun 01; 41(11):1095-101. Mendelson J, Jones RT, Welm S, Brown J, Batki SL. PMID: 9146820.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    77. Measurement properties of quantitative urine benzoylecgonine in clinical trials research. Addiction. 1997 Mar; 92(3):297-302. Delucchi KL, Jones RT, Batki SL. PMID: 9219391.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    78. A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):13060-5. McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, Rojas E, Spesny M, Baharloo S, Blankenship K, Peterson A, Tyler D, Shimayoshi N, Tobey C, Batki S, Vinogradov S, Meza L, Gallegos A, Fournier E, Smith LB, Barondes SH, Sandkuijl LA, Freimer NB. PMID: 8917544; PMCID: PMC24046.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    79. Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. Am J Drug Alcohol Abuse. 1996 Nov; 22(4):475-87. Ferrando SJ, Wall TL, Batki SL, Sorensen JL. PMID: 8911586.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    80. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 1996 Jun; 41(2):137-42. Batki SL, Washburn AM, Delucchi K, Jones RT. PMID: 8809502.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    81. An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees. Am J Med Genet. 1996 May 31; 67(3):254-63. Freimer NB, Reus VI, Escamilla M, Spesny M, Smith L, Service S, Gallegos A, Meza L, Batki S, Vinogradov S, Leon P, Sandkuijl LA. PMID: 8725744.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    82. Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet. 1996 Apr; 12(4):436-41. Freimer NB, Reus VI, Escamilla MA, McInnes LA, Spesny M, Leon P, Service SK, Smith LB, Silva S, Rojas E, Gallegos A, Meza L, Fournier E, Baharloo S, Blankenship K, Tyler DJ, Batki S, Vinogradov S, Weissenbach J, Barondes SH, Sandkuijl LA. PMID: 8630501.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    83. Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits. Psychiatr Serv. 1996 Feb; 47(2):119-20, 142. Herbst MD, Batki SL, Manfredi LB, Jones T. PMID: 8825244.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    84. Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend. 1995 Mar; 37(3):261-9. Wall TL, Sorensen JL, Batki SL, Delucchi KL, London JA, Chesney MA. PMID: 7796721.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    85. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol. 1993 Aug; 13(4):243-50. Batki SL, Manfredi LB, Jacob P, Jones RT. PMID: 8376611.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    86. HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management. J Psychoactive Drugs. 1991 Apr-Jun; 23(2):217-24. Ferrando SJ, Batki SL. PMID: 1662716.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Buspirone in drug users with AIDS or AIDS-related complex. J Clin Psychopharmacol. 1990 Jun; 10(3 Suppl):111S-115S. Batki SL. PMID: 2376626.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    88. Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis. West J Med. 1990 May; 152(5):547-52. Batki SL. PMID: 2190423; PMCID: PMC1002409.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    89. Substance abuse and AIDS: the need for mental health services. New Dir Ment Health Serv. 1990; (48):55-67. Batki SL. PMID: 2077391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. Fluoxetine for cocaine abuse in methadone patients: preliminary findings. NIDA Res Monogr. 1990; 105:516-7. Batki SL, Manfredi LB, Sorensen JL, Jacob P, Dumontet R, Jones RT. PMID: 1876106.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. Changes in needle sharing and syringe cleaning among San Francisco drug abusers. N Engl J Med. 1989 Mar 23; 320(12):807. Sorensen JL, Guydish J, Costantini M, Batki SL. PMID: 2922030.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    92. Methadone maintenance program for AIDS-affected opiate addicts. J Subst Abuse Treat. 1989; 6(2):87-94. Sorensen JL, Batki SL, Good P, Wilkinson K. PMID: 2746716.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    93. HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report. NIDA Res Monogr. 1989; 95:405-6. Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P. PMID: 2641010.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Treatment of intravenous drug users with AIDS: the role of methadone maintenance. J Psychoactive Drugs. 1988 Apr-Jun; 20(2):213-6. Batki SL. PMID: 3418453.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. Psychiatric aspects of treatment of i.v. drug abusers with AIDS. Hosp Community Psychiatry. 1988 Apr; 39(4):439-41. Batki SL, Sorensen JL, Faltz B, Madover S. PMID: 3371914.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    96. Psychiatric and ethical issues in the care of patients with AIDS. Psychosomatics. 1986 Aug; 27(8):562-6. Dilley JW, Shelp EE, Batki SL. PMID: 3749429.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Steven's Networks
    Concepts (362)
    Derived automatically from this person's publications.
    Co-Authors (58)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department